201 related articles for article (PubMed ID: 20046145)
1. Resistance considerations in sequencing of antiretroviral therapy in low-middle income countries with currently available options.
De Luca A; Prosperi M; Bracciale L
Curr Opin HIV AIDS; 2010 Jan; 5(1):27-37. PubMed ID: 20046145
[TBL] [Abstract][Full Text] [Related]
2. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
Bassetti D; Cargnel A
Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
[TBL] [Abstract][Full Text] [Related]
3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries.
De Luca A; Hamers RL; Schapiro JM
J Infect Dis; 2013 Jun; 207 Suppl 2():S63-9. PubMed ID: 23687291
[TBL] [Abstract][Full Text] [Related]
5. Sequencing of antiretroviral therapy in children in low- and middle-income countries.
Sohn AH; Nuttall JJ; Zhang F
Curr Opin HIV AIDS; 2010 Jan; 5(1):54-60. PubMed ID: 20046148
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.
Duran AS; Losso MH; Salomón H; Harris DR; Pampuro S; Soto-Ramirez LE; Duarte G; de Souza RS; Read JS;
AIDS; 2007 Jan; 21(2):199-205. PubMed ID: 17197811
[TBL] [Abstract][Full Text] [Related]
7. Genotypic resistance tests for the management of the HIV-infected pregnant patient in Africa.
Giaquinto C
Scand J Infect Dis Suppl; 2003; 106():88-90. PubMed ID: 15000594
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 drug resistance and mother-to-child transmission.
Morris L; Pillay C; Gray G; McIntyre J
SADJ; 2001 Dec; 56(12):614-6. PubMed ID: 11887450
[TBL] [Abstract][Full Text] [Related]
9. Current and future management of treatment failure in low- and middle-income countries.
Boyd MA
Curr Opin HIV AIDS; 2010 Jan; 5(1):83-9. PubMed ID: 20046152
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral resistance mutations among pregnant human immunodeficiency virus type 1-infected women and their newborns in the United States: vertical transmission and clades.
Palumbo P; Holland B; Dobbs T; Pau CP; Luo CC; Abrams EJ; Nesheim S; Vink P; Respess R; Bulterys M;
J Infect Dis; 2001 Nov; 184(9):1120-6. PubMed ID: 11598834
[TBL] [Abstract][Full Text] [Related]
11. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
[TBL] [Abstract][Full Text] [Related]
12. Impact of genotypic resistance testing on selection of salvage regimen in clinical practice.
Haupts S; Ledergerber B; Böni J; Schüpbach J; Kronenberg A; Opravil M; Flepp M; Speck RF; Grube C; Rentsch K; Weber R; Günthard HF;
Antivir Ther; 2003 Oct; 8(5):443-54. PubMed ID: 14640392
[TBL] [Abstract][Full Text] [Related]
13. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R;
Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for use of antiretroviral therapy for HIV infected individuals in India (ART guidelines 2008).
Pujari S; Patel A; Joshi SR; Gangakhedkar R; Kumarasamy N; Gupta SB;
J Assoc Physicians India; 2008 May; 56():339-48, 353-71. PubMed ID: 18700643
[No Abstract] [Full Text] [Related]
15. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.
Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Piyavong B; Chumpathat N; Chantratita W
Clin Infect Dis; 2007 Feb; 44(3):447-52. PubMed ID: 17205457
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.
Sitnitskaya Y; Rochford G; Rigaud M; Essajee S; Pollack H; Krasinski K; Borkowsky W
Clin Infect Dis; 2001 Jul; 33(1):e3-7. PubMed ID: 11389511
[TBL] [Abstract][Full Text] [Related]
17. Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy.
Lihana RW; Lwembe RM; Bi X; Ochieng W; Panikulam A; Palakudy T; Musoke R; Owens M; Ishizaki A; Okoth FA; Songok EM; Ichimura H
J Clin Virol; 2011 Oct; 52(2):123-8. PubMed ID: 21798798
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral drug resistance among HIV-1 infected children failing treatment.
Mullen J; Leech S; O'Shea S; Chrystie IL; Du Mont G; Ball C; Sharland M; Cottam F; Zuckerman M; Rice P; Easterbrook P
J Med Virol; 2002 Nov; 68(3):299-304. PubMed ID: 12226814
[TBL] [Abstract][Full Text] [Related]
19. Genotypic resistance testing in HIV-infected pregnant women in an urban setting.
Shah SS; Crane M; Monaghan K; McGowan JP
Int J STD AIDS; 2004 Jun; 15(6):384-7. PubMed ID: 15186583
[TBL] [Abstract][Full Text] [Related]
20. Drug-resistant HIV-1 in the semen of men receiving antiretroviral therapy with acute sexually transmitted infections.
Taylor S; Sadiq ST; Weller I; Kaye S; Workman J; Cane PA; Bennett J; Copas AJ; Drake SM; Pillay D
Antivir Ther; 2003 Oct; 8(5):479-83. PubMed ID: 14640396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
